CA, UNITED STATES, February 25, 2026 / EINPresswire.com / — Medical device manufacturer WONBIOGEN (CEO Kim Won-il) is ...

In a challenge brought by Johnson & Johnson Consumer Inc. (JJCI), BBB National Programs' National Advertising Division recommended that ASO LLC discontinue its "2x faster healing" claims for its ...

As aging populations and rising diabetes rates drive an increase in chronic wounds, more patients face the risk of ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...